CNN — A senior U.S. Department of Health and Human Services official in a letter to the Drug …
Tag:
Lowerrisk
-
-
Medicine
FDA Grants Priority Review to Luspatercept for First-line Treatment of Anemia in Lower-risk MDS
FDA seeks to expand current indication for luspatercept-aamt (Reblozyl) to include treatment of anemia in patients with very …